Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
7.10
-0.47 (-6.21%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Evolus Revenue
Evolus had revenue of $84.08M in the quarter ending June 30, 2026, with 21.18% growth. This brings the company's revenue in the last twelve months to $316.49M, up 13.87% year-over-year. In the year 2025, Evolus had annual revenue of $297.18M with 11.61% growth. That makes Evolus the 14,141st largest company in the world by revenue and 2,588th in the United States.
Revenue (ttm)
$316.49M
Revenue Growth
+13.87%
P/S Ratio
1.48
Revenue / Employee
$896,567
Employees
353
Market Cap
468.96M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 297.18M | 30.90M | 11.61% |
| Dec 31, 2024 | 266.27M | 64.19M | 31.76% |
| Dec 31, 2023 | 202.09M | 53.47M | 35.98% |
| Dec 31, 2022 | 148.62M | 48.94M | 49.10% |
| Dec 31, 2021 | 99.67M | 43.13M | 76.29% |
| Dec 31, 2020 | 56.54M | 21.62M | 61.89% |
| Dec 31, 2019 | 34.93M | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tilray Brands | 963.10M |
| Evotec SE | 819.47M |
| Collegium Pharmaceutical | 808.21M |
| Emergent BioSolutions | 770.20M |
| Ironwood Pharmaceuticals | 389.32M |
| Canopy Growth | 206.77M |
| Kamada | 191.85M |
| Glass House Brands | 176.98M |
EOLS News
- 4 days ago - Evolus Expands Innovation Pipeline with Novel Injectable Hair Restoration Program - Business Wire
- 6 days ago - EOLS Investors with $100,000 in Losses Have Opportunity to Join Evolus, Inc. Fraud Investigation with SBS Law - Business Wire
- 16 days ago - FDA sends letter to Evolus over ‘misleading’ Jeuveau ad - TheFly
- 16 days ago - Evolus falls 5% to $7.12 after FDA send letter over marketing - TheFly
- 17 days ago - Evolus launches Wings by Evolus charitable platform - TheFly
- 17 days ago - Evolus Launches Wings by Evolus, a New Charitable Platform to Mobilize Its Community in Support of Important Causes - Business Wire
- 5 weeks ago - Evolus weakness a buying opportunity, says Mizuho - TheFly
- 2 months ago - Evolus reports Q2 EPS (12c), consensus (4c) - TheFly